1. Bristol‐Myers Squibb Company.YERVOY (ipilimumab). U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125377s094lbl.pdf. Revised April 2018. Accessed October 5 2020.
2. Merck Sharp & Dohme Corp.KEYTRUDA (pembrolizumab). U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125514s066lbl.pdf. Revised January 2020. Accessed October 5 2020.
3. Bristol‐Myers Squibb Company.OPDIVO (nivolumab). U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125554s070lbl.pdf. Revised April 2019. Accessed October 5 2020.
4. Genentech Inc.TECENTRIQ (atezolizumab). U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761034s018lbl.pdf. Revised March 2019. Accessed October 5 2020.
5. EMD Serono Inc.BAVENCIO (avelumab). U.S. Food and Drug Administration website.https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761049s006lbl.pdf. Revised May 2019. Accessed October 5 2020.